文献速递妇科生殖医学

宫腔镜子宫纵隔切除术后的自然妊娠生殖结局:系统综述与Meta分析

Reproductive outcomes of natural pregnancy after hysteroscopic septum resection in patients with a septate uterus: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-10-08

该系统综述与Meta分析纳入5项队列研究和22项病例系列共1506例患者,评估宫腔镜子宫纵隔切除术后自然妊娠的生殖结局。复发性流产患者术后活产率66%,活产风险比为1.77;原发不孕患者术后活产率37%,活产风险比为4.12;继发不孕患者的疗效不明确。

要点

  • 复发性流产患者行宫腔镜子宫纵隔切除术后活产率66%,活产风险比为1.77。
  • 原发不孕患者术后活产率37%,活产风险比为4.12,临床妊娠风险比为2.28。
  • 继发不孕患者术后活产率41%(95%CI 2-88),疗效不明确。

核心结论

  • 宫腔镜子宫纵隔切除术与复发性流产或原发不孕患者的活产率升高及流产率降低相关,提示该手术可能改善这些患者的生殖结局。
  • 继发不孕患者行子宫纵隔切除术的有效性不明确。
  • 上述发现受纳入研究质量的限制,需要进一步开展仅纳入复发性流产或原发不孕患者的随机对照试验。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Cochrane Library、Web of Science、中国知网、万方数据知识服务平台、维普数据库和中国生物医学文献数据库,检索时间从建库至2021年7月。
  • 纳入随机对照试验、队列研究和病例系列,研究对象为复发性流产、原发不孕或继发不孕的子宫纵隔患者,无论是否有对照组。
  • 共纳入5项队列研究和22项病例系列,涉及1506例患者。

主要发现

  • 复发性流产患者行宫腔镜子宫纵隔切除术后活产率66%(95%CI 59-72),活产风险比为1.77(95%CI 1.26-2.49,P=.001,I²=0%)。
  • 复发性流产患者术后早产风险比为0.15(95%CI 0.04-0.53,P=.003,I²=0%),流产风险比为0.36(95%CI 0.20-0.66,P=.0009,I²=0%)。
  • 原发不孕患者术后活产风险比为4.12(95%CI 1.19-14.29,P=.03,I²=0%),临床妊娠风险比为2.28(95%CI 1.04-4.98,P=.04,I²=0%),术后活产率37%(95%CI 30-44)。
  • 原发不孕患者术后流产风险比为0.19(95%CI 0.06-0.56,P=.003)。
  • 继发不孕患者术后活产率41%(95%CI 2-88),其疗效不明确。

局限性

  • 这些发现受纳入研究质量的限制。
  • 需要进一步开展仅纳入复发性流产或原发不孕患者的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this systematic review and meta-analysis was to analyze the reproductive outcomes of natural pregnancy after hysteroscopic septum resection in patients with recurrent miscarriage, primary infertility, or secondary infertility. DATA SOURCES: The PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, VIP Database, and Chinese Biomedical Literature Database (CBM) databases were electronically searched. The search time frame was from inception up to July 2021. The English search terms were (arcuate* and uter*), (sept* and uter*), (subseptate* and uter*), metroplast*, septoplast*, and resect*. STUDY ELIGIBILITY CRITERIA: Selection criteria included randomized controlled trials, cohort studies, and case series that explored reproductive outcomes after hysteroscopic septum resection in patients with recurrent miscarriage, primary infertility, or secondary infertility with or without a control group. METHODS: The primary outcomes were the live birth rate and eventual postoperative live birth rate after hysteroscopic septum resection. The secondary outcomes were the clinical pregnancy rate, preterm birth rate, and miscarriage rate. Study-level proportions of outcomes were transformed using the Freeman-Tukey double-arcsine transformation to calculate pooled values for the postoperative rates; the counted data were analyzed using relative risk as the effect analysis statistic, and each effect size was provided with its 95% confidence interval. Heterogeneity between the results of the included studies was analyzed using the I2 test. RESULTS: Overall, 5 cohort studies and 22 case series involving 1506 patients were included. In patients with a septate uterus and recurrent miscarriage, hysteroscopic septum resection was associated with an increased live birth rate (relative risk, 1.77; 95% confidence interval, 1.26-2.49; P=.001; I2=0%), resulting in a postoperative live birth rate of 66% (95% confidence interval, 59-72), and septum resection was associated with a reduced preterm birth rate (relative risk, 0.15; 95% confidence interval, 0.04-0.53; P=.003; I2=0%) and miscarriage rate (relative risk, 0.36; 95% confidence interval, 0.20-0.66; P=.0009; I2=0%). In patients with a septate uterus and primary infertility, hysteroscopic septum resection was associated with an increased live birth rate (relative risk, 4.12; 95% confidence interval, 1.19-14.29; P=.03; I2=0%) and clinical pregnancy rate (relative risk, 2.28; 95% confidence interval, 1.04-4.98; P=.04; I2=0%). The postoperative live birth rate was 37% (95% confidence interval, 30-44), and the miscarriage rate of patients with primary infertility was reduced (relative risk, 0.19; 95% confidence interval, 0.06-0.56; P=.003). The efficacy of hysteroscopic septum resection in patients with secondary infertility was unclear. However, their postoperative live birth rate was found to be 41% (95% confidence interval, 2-88). CONCLUSION: Hysteroscopic septum resection is associated with an increased live birth rate and a reduced miscarriage rate in patients with recurrent miscarriage or primary infertility, indicating that septum resection may improve the reproductive outcomes of these patients. The effectiveness of septum resection was unclear for patients with secondary infertility. These findings are limited by the quality of the included studies, warranting further randomized controlled trials, including only patients with recurrent miscarriage or primary infertility.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Jiang Y, Wang L, Wang B, et al. Reproductive outcomes of natural pregnancy after hysteroscopic septum resection in patients with a septate uterus: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022. PMID: 36220552. doi:10.1016/j.ajogmf.2022.100762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。